Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors
The purpose of this study was to investigate whether the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can be used as supplementary tools to differentiate between benign, borderline, and malignant ovarian tumors. The ratio of patients with benign to borderline to malignant tu...
Gespeichert in:
Veröffentlicht in: | Journal of clinical medicine 2022-03, Vol.11 (5), p.1355 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 5 |
container_start_page | 1355 |
container_title | Journal of clinical medicine |
container_volume | 11 |
creator | Yun, Tae Hui Jeong, Yoon Young Lee, Sun Jae Choi, Youn Seok Ryu, Jung Min |
description | The purpose of this study was to investigate whether the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can be used as supplementary tools to differentiate between benign, borderline, and malignant ovarian tumors. The ratio of patients with benign to borderline to malignant tumors was planned as 3:1:2 considering the incidence of each disease. Consecutive patients were enrolled retrospectively. Preoperative complete blood counts with differentials were investigated, and calculated NLRs and PLRs were analyzed. A total of 630 patients with ovarian tumors were enrolled in this study. The final histopathological results revealed that 318 patients had benign, 108 patients had epithelial borderline, and 204 patients had epithelial malignant ovarian tumors. The NLR and PLR were significantly higher in malignant than in benign or borderline ovarian tumors, and they did not differ significantly between benign and borderline ovarian tumors. The diagnostic cut-off value of NLR for differentiating between benign or borderline and malignant tumors was 2.36, whereas that of PLR for differentiating between benign/borderline and malignancy was 150.02. High preoperative NLR and PLR indicate that the likelihood of epithelial ovarian cancer is higher than that of benign or borderline tumors. |
doi_str_mv | 10.3390/jcm11051355 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8911107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2638719232</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-529e054082219b4396dafaf85d5b8790367b13e8540f9c374b1d333d5e0d88503</originalsourceid><addsrcrecordid>eNpdkUtv1DAUhSMEolXpij2yxAaJBvyIY3uDRMtTGmiFytpykpsZjxw7tZ2R5lfwl3FpqQa8se_1p6Nz76mq5wS_YUzht9t-IgRzwjh_VB1TLESNmWSPD95H1WlKW1yOlA0l4ml1xDhtZdO0x9Wv77DkGOaNdfVqP82b0O8zIOMHdOVMBgf5sP_DZBsSsh5dRQgzxFLvAH2w4wgRfLbGlcKsfUg2oTCic_B27c_QeYgDRGc9nP0R_2Zc6Ruf0eXORGs8ul6mENOz6sloXILT-_uk-vnp4_XFl3p1-fnrxftV3TdY5ZpTBZg3WFJKVNcw1Q5mNKPkA--kUJi1oiMMZEFG1TPRdGRgjA0c8CAlx-ykenenOy_dBENfvEfj9BztZOJeB2P1vz_ebvQ67LRUpCxcFIFX9wIx3CyQsp5s6sE54yEsSdOWSUEUZbSgL_9Dt2GJvox3SwnBeKvaQr2-o_oYUoowPpghWN9mrQ-yLvSLQ_8P7N9k2W96aKZY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2637735696</pqid></control><display><type>article</type><title>Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Yun, Tae Hui ; Jeong, Yoon Young ; Lee, Sun Jae ; Choi, Youn Seok ; Ryu, Jung Min</creator><creatorcontrib>Yun, Tae Hui ; Jeong, Yoon Young ; Lee, Sun Jae ; Choi, Youn Seok ; Ryu, Jung Min</creatorcontrib><description>The purpose of this study was to investigate whether the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can be used as supplementary tools to differentiate between benign, borderline, and malignant ovarian tumors. The ratio of patients with benign to borderline to malignant tumors was planned as 3:1:2 considering the incidence of each disease. Consecutive patients were enrolled retrospectively. Preoperative complete blood counts with differentials were investigated, and calculated NLRs and PLRs were analyzed. A total of 630 patients with ovarian tumors were enrolled in this study. The final histopathological results revealed that 318 patients had benign, 108 patients had epithelial borderline, and 204 patients had epithelial malignant ovarian tumors. The NLR and PLR were significantly higher in malignant than in benign or borderline ovarian tumors, and they did not differ significantly between benign and borderline ovarian tumors. The diagnostic cut-off value of NLR for differentiating between benign or borderline and malignant tumors was 2.36, whereas that of PLR for differentiating between benign/borderline and malignancy was 150.02. High preoperative NLR and PLR indicate that the likelihood of epithelial ovarian cancer is higher than that of benign or borderline tumors.</description><identifier>ISSN: 2077-0383</identifier><identifier>EISSN: 2077-0383</identifier><identifier>DOI: 10.3390/jcm11051355</identifier><identifier>PMID: 35268446</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Biopsy ; Blood diseases ; Blood platelets ; Clinical medicine ; Lymphocytes ; Neutrophils ; Ovarian cancer ; Software ; Standard deviation ; Surgery ; Tumors ; Variance analysis</subject><ispartof>Journal of clinical medicine, 2022-03, Vol.11 (5), p.1355</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-529e054082219b4396dafaf85d5b8790367b13e8540f9c374b1d333d5e0d88503</citedby><cites>FETCH-LOGICAL-c409t-529e054082219b4396dafaf85d5b8790367b13e8540f9c374b1d333d5e0d88503</cites><orcidid>0000-0003-0125-9754 ; 0000-0002-8552-6049 ; 0000-0001-8901-9434 ; 0000-0001-7434-4541</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911107/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911107/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35268446$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yun, Tae Hui</creatorcontrib><creatorcontrib>Jeong, Yoon Young</creatorcontrib><creatorcontrib>Lee, Sun Jae</creatorcontrib><creatorcontrib>Choi, Youn Seok</creatorcontrib><creatorcontrib>Ryu, Jung Min</creatorcontrib><title>Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors</title><title>Journal of clinical medicine</title><addtitle>J Clin Med</addtitle><description>The purpose of this study was to investigate whether the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can be used as supplementary tools to differentiate between benign, borderline, and malignant ovarian tumors. The ratio of patients with benign to borderline to malignant tumors was planned as 3:1:2 considering the incidence of each disease. Consecutive patients were enrolled retrospectively. Preoperative complete blood counts with differentials were investigated, and calculated NLRs and PLRs were analyzed. A total of 630 patients with ovarian tumors were enrolled in this study. The final histopathological results revealed that 318 patients had benign, 108 patients had epithelial borderline, and 204 patients had epithelial malignant ovarian tumors. The NLR and PLR were significantly higher in malignant than in benign or borderline ovarian tumors, and they did not differ significantly between benign and borderline ovarian tumors. The diagnostic cut-off value of NLR for differentiating between benign or borderline and malignant tumors was 2.36, whereas that of PLR for differentiating between benign/borderline and malignancy was 150.02. High preoperative NLR and PLR indicate that the likelihood of epithelial ovarian cancer is higher than that of benign or borderline tumors.</description><subject>Biopsy</subject><subject>Blood diseases</subject><subject>Blood platelets</subject><subject>Clinical medicine</subject><subject>Lymphocytes</subject><subject>Neutrophils</subject><subject>Ovarian cancer</subject><subject>Software</subject><subject>Standard deviation</subject><subject>Surgery</subject><subject>Tumors</subject><subject>Variance analysis</subject><issn>2077-0383</issn><issn>2077-0383</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkUtv1DAUhSMEolXpij2yxAaJBvyIY3uDRMtTGmiFytpykpsZjxw7tZ2R5lfwl3FpqQa8se_1p6Nz76mq5wS_YUzht9t-IgRzwjh_VB1TLESNmWSPD95H1WlKW1yOlA0l4ml1xDhtZdO0x9Wv77DkGOaNdfVqP82b0O8zIOMHdOVMBgf5sP_DZBsSsh5dRQgzxFLvAH2w4wgRfLbGlcKsfUg2oTCic_B27c_QeYgDRGc9nP0R_2Zc6Ruf0eXORGs8ul6mENOz6sloXILT-_uk-vnp4_XFl3p1-fnrxftV3TdY5ZpTBZg3WFJKVNcw1Q5mNKPkA--kUJi1oiMMZEFG1TPRdGRgjA0c8CAlx-ykenenOy_dBENfvEfj9BztZOJeB2P1vz_ebvQ67LRUpCxcFIFX9wIx3CyQsp5s6sE54yEsSdOWSUEUZbSgL_9Dt2GJvox3SwnBeKvaQr2-o_oYUoowPpghWN9mrQ-yLvSLQ_8P7N9k2W96aKZY</recordid><startdate>20220301</startdate><enddate>20220301</enddate><creator>Yun, Tae Hui</creator><creator>Jeong, Yoon Young</creator><creator>Lee, Sun Jae</creator><creator>Choi, Youn Seok</creator><creator>Ryu, Jung Min</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0125-9754</orcidid><orcidid>https://orcid.org/0000-0002-8552-6049</orcidid><orcidid>https://orcid.org/0000-0001-8901-9434</orcidid><orcidid>https://orcid.org/0000-0001-7434-4541</orcidid></search><sort><creationdate>20220301</creationdate><title>Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors</title><author>Yun, Tae Hui ; Jeong, Yoon Young ; Lee, Sun Jae ; Choi, Youn Seok ; Ryu, Jung Min</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-529e054082219b4396dafaf85d5b8790367b13e8540f9c374b1d333d5e0d88503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biopsy</topic><topic>Blood diseases</topic><topic>Blood platelets</topic><topic>Clinical medicine</topic><topic>Lymphocytes</topic><topic>Neutrophils</topic><topic>Ovarian cancer</topic><topic>Software</topic><topic>Standard deviation</topic><topic>Surgery</topic><topic>Tumors</topic><topic>Variance analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yun, Tae Hui</creatorcontrib><creatorcontrib>Jeong, Yoon Young</creatorcontrib><creatorcontrib>Lee, Sun Jae</creatorcontrib><creatorcontrib>Choi, Youn Seok</creatorcontrib><creatorcontrib>Ryu, Jung Min</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yun, Tae Hui</au><au>Jeong, Yoon Young</au><au>Lee, Sun Jae</au><au>Choi, Youn Seok</au><au>Ryu, Jung Min</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors</atitle><jtitle>Journal of clinical medicine</jtitle><addtitle>J Clin Med</addtitle><date>2022-03-01</date><risdate>2022</risdate><volume>11</volume><issue>5</issue><spage>1355</spage><pages>1355-</pages><issn>2077-0383</issn><eissn>2077-0383</eissn><abstract>The purpose of this study was to investigate whether the neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) can be used as supplementary tools to differentiate between benign, borderline, and malignant ovarian tumors. The ratio of patients with benign to borderline to malignant tumors was planned as 3:1:2 considering the incidence of each disease. Consecutive patients were enrolled retrospectively. Preoperative complete blood counts with differentials were investigated, and calculated NLRs and PLRs were analyzed. A total of 630 patients with ovarian tumors were enrolled in this study. The final histopathological results revealed that 318 patients had benign, 108 patients had epithelial borderline, and 204 patients had epithelial malignant ovarian tumors. The NLR and PLR were significantly higher in malignant than in benign or borderline ovarian tumors, and they did not differ significantly between benign and borderline ovarian tumors. The diagnostic cut-off value of NLR for differentiating between benign or borderline and malignant tumors was 2.36, whereas that of PLR for differentiating between benign/borderline and malignancy was 150.02. High preoperative NLR and PLR indicate that the likelihood of epithelial ovarian cancer is higher than that of benign or borderline tumors.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35268446</pmid><doi>10.3390/jcm11051355</doi><orcidid>https://orcid.org/0000-0003-0125-9754</orcidid><orcidid>https://orcid.org/0000-0002-8552-6049</orcidid><orcidid>https://orcid.org/0000-0001-8901-9434</orcidid><orcidid>https://orcid.org/0000-0001-7434-4541</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2077-0383 |
ispartof | Journal of clinical medicine, 2022-03, Vol.11 (5), p.1355 |
issn | 2077-0383 2077-0383 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8911107 |
source | MDPI - Multidisciplinary Digital Publishing Institute; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
subjects | Biopsy Blood diseases Blood platelets Clinical medicine Lymphocytes Neutrophils Ovarian cancer Software Standard deviation Surgery Tumors Variance analysis |
title | Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T18%3A19%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neutrophil-Lymphocyte%20and%20Platelet-Lymphocyte%20Ratios%20in%20Preoperative%20Differential%20Diagnosis%20of%20Benign,%20Borderline,%20and%20Malignant%20Ovarian%20Tumors&rft.jtitle=Journal%20of%20clinical%20medicine&rft.au=Yun,%20Tae%20Hui&rft.date=2022-03-01&rft.volume=11&rft.issue=5&rft.spage=1355&rft.pages=1355-&rft.issn=2077-0383&rft.eissn=2077-0383&rft_id=info:doi/10.3390/jcm11051355&rft_dat=%3Cproquest_pubme%3E2638719232%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2637735696&rft_id=info:pmid/35268446&rfr_iscdi=true |